Bioton taps solar power with BNP Paribas partnership

Polish biotechnology company Bioton has joined forces with BNP Paribas Leasing Solutions to advance its sustainability efforts through the installation of a 1.9 MW solar energy plant near its manufacturing site.

As a top producer of human insulin and a champion of innovative healthcare solutions, Bioton sought to reduce its environmental footprint while improving energy efficiency. Rising energy costs and underutilised space near its factory prompted the company to pursue a solar energy project that would meet up to 15% of its total energy needs.

To support this green initiative, BNP Paribas Leasing Solutions provided a customised financing solution, enabling the installation and seamless integration of the photovoltaic panels. The project not only delivers long-term cost savings but also enhances Bioton’s energy independence and sustainability profile.

“This partnership with BNP Paribas Leasing Solutions is a great example of how organisations can work together to facilitate the energy transition,” said a sales manager from Bioton. “This renewable energy source is an integral part of our energy transformation process.”

The benefits of the collaboration are already clear including reduced energy costs, boosting Bioton’s financial resilience; increased operational efficiency, with a more stable energy supply; and stronger environmental credentials, marking Bioton as a leader in green innovation within the pharmaceutical industry.